Biographica and Hudson River Biotechnology are collaborating to enhance crop trait development, focusing on disease resistance and advanced genome editing techniques.
The partnership between UK startup Biographica and Dutch genome editing firm Hudson River Biotechnology aims to streamline the crop trait development process from initial target discovery to the creation of edited commercial varieties. This collaboration combines Biographica's computational power in identifying valuable gene targets with Hudson River's expertise in genome editing, transformation, and plant regeneration.
Initially, the partners will concentrate on enhancing tomatoes, with plans to extend their efforts to other crops down the line. Dominic Hall, cofounder of Biographica, emphasizes that Hudson River possesses significant genome editing capabilities. "They can leverage our predictive capabilities to create edited varieties tailored to their customers’ challenges," Hall explained.
Integrating Technologies for Enhanced Crop Traits
This partnership introduces an innovative model in which customers present specific trait challenges to Hudson River. The company, in turn, utilizes Biographica's data-driven insights to determine priority gene targets for gene edits. This collaboration is particularly advantageous when genetic targets are elusive or when companies encounter barriers due to existing patents. “It’s a case of bring us your most difficult trait problems,” stated Hall. These scenarios could involve complex trait issues that lack sufficient data for resolution or situations complicated by intellectual property restrictions.
Under their commercial framework, customers interact with Hudson River, which handles the project management, while costs and any potential gains are shared between the two organizations. Hudson River is noted for its capacity to edit challenging crops like strawberries, and this partnership enables customers to tackle multifaceted trait problems effectively.
Addressing the Discovery Bottleneck
The process of identifying gene targets for edits has traditionally relied on methodologies like Genome-Wide Association Studies (GWAS) and Quantitative Trait Loci (QTL) mapping. GWAS links variations across plant genomes with specific traits, while QTL mapping analyzes inheritance patterns to narrow genomic regions associated with desired traits. However, these approaches often demonstrate correlation rather than causation and fail to prioritize gene targets for deeper investigation.
Biographica’s platform employs multi-modal machine learning, enabling it to predict influential genes, assess their interactions, and rank them based on their viability as gene editing targets. This technology uses foundation models trained on diverse genomic datasets to pinpoint genes that causally influence traits and design corresponding edits proactively. The iterative nature of their approach allows for continuous adjustment based on experimental feedback, refining the predictive model.
Modulating Susceptibility Genes
Beyond identifying novel targets, Biographica is innovating in the design of genetic edits. Rather than simply turning genes on or off, the company is focused on predicting how modifications can influence gene expression in various contexts. This nuanced strategy aims to address susceptibility genes—those that can be exploited by pathogens but are also essential for normal plant growth—without sacrificing yield.
Hall explained this approach, saying, “We explore whether we can modulate the expression of these genes under specific conditions to reduce plant susceptibility, ensuring no detrimental effects on yield.” While traditional knockouts might be the best solution for some, Biographica and Hudson River are also investigating regulatory DNA changes that dictate gene activity, providing a more sophisticated editing option that could yield longer-lasting disease resistance.
Market-Driven Trait Development
Alongside its partnership with Hudson River, Biographica is engaging in its own trait development initiatives. Recently, the company secured a £7 million ($9.5 million) funding round, which will support various projects driven by market demand. Hall noted that current conversations with breeders indicate a strong interest in developing disease-resistant traits, while opportunities also exist in enhancing crop quality and nutritional value.
This collaborative effort is driven by a market pull approach, providing insights into the most pressing challenges faced by breeders and fostering the development of meaningful trait enhancements. By combining Hudson River’s established genome editing techniques with Biographica’s innovative operational framework, the partnership seeks to uncover valuable traits that traditional breeding methods have yet to achieve.
Looking Ahead
As Biographica and Hudson River delve deeper into genome editing and trait development, industry stakeholders will be watching closely for advancements that could reshape agricultural practices. This partnership not only highlights the importance of interdisciplinary collaboration in tackling challenging crop trait issues but also signals a shift toward more precise, data-driven methodologies in agricultural biotechnology.
The increasing demand for crops that can withstand environmental stressors, support sustainable farming practices, and provide enhanced nutritional content underscores the critical role of innovations like those being developed through this collaboration. By addressing complex trait problems and leveraging advanced technologies, Biographica and Hudson River are positioning themselves as key players in the future of agriculture.
For further insights, the conversations around this collaboration and its broader implications for crop genome editing will continue to evolve, highlighting the significant potential of such partnerships to contribute to a more resilient agricultural landscape.
